Cite

HARVARD Citation

    Upton, P. et al. (2023). An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension. Developmental dynamics. 252 (3), pp. 327-342. [Online]. 
  
Back to record